For Public Health Institutes & Reference Laboratories
- Home
- Who We Serve
- Public Health & Government
Surveillance data is only useful while it is still actionable. We work to turnaround measured in days, not weeks.
Sequencing capacity across African public health laboratories expanded sharply during the COVID-19 response, and much of it is now under-used because the analysis step is the constraint. Genomes are generated, then wait.
We work with surveillance programmes on a standing basis: an agreed turnaround per batch, a standard report format suitable for circulation to health authorities, and a deliberate plan to transfer the pipeline to your own staff.
What Usually Brings People To Us
Sequencing capacity outpacing analysis capacity
Instruments installed during the pandemic response, without matching analyst posts.
Results arriving too late to act on
A lineage report three weeks after the outbreak is a publication, not a public health tool.
Submission backlogs to GISAID, ENA and NCBI
Data that is never deposited helps nobody, including you.
Tools that misclassify African lineages
Reference databases are built disproportionately on non-African sequences.
What You Get
- Agreed turnaround per sequencing batch, contractually fixed
- One pipeline handling both Illumina and Nanopore inputs
- Consensus genomes with per-genome quality flags, honestly reported
- Lineage, clade and resistance profiling in an interpretable report
- Submission-ready packages for GISAID, ENA and NCBI
- A Nextstrain build your team hosts and updates itself
- Training so the pipeline moves in-house over the life of the agreement
Tell us your batch size and cycle, and we will quote a standing turnaround.
Where to go next
